- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03254979
Optimizing the Primary Prevention of Type-2 Diabetes in Primary Health Care (PREDIAPS)
How to Engage Primary Health Care Providers in an Inter-professional Collaborative Modeling Process for the Optimization of Type-2 Diabetes Primary Prevention: a Randomized Hybrid Implementation Trial
RATIONALE The translation into clinical practice of Primary Care (PHC) of effective and sustainable interventions to prevent of type-2 diabetes (T2D) remains an unresolved challenge. Leadership, active involvement of professionals, facilitation and adaptation to the local context and their determinants are known to be key components in the success of implementation strategies that seek to optimize clinical practice. However, one of the areas in which there is still no evidence is related to the effectiveness of different strategies to engage healthcare professionals in such innovation processes. Especially in real-world Primary Care clinical contexts characterized by work overload and limited time, with marked differentiation of professional status, both at the level of identity and competency.
OBJECTIVES To assess the effect of PHC providers engagement procedure in the creation and execution of a facilitated collaborative modelling process, in the adoption, reach, implementation and effectiveness of the recommended clinical practice for the prevention of type-2 Diabetes
METHODOLOGY
Randomized cluster hybrid trial in which 9 PHC centres from Osakidetza will be allocated to two different strategies to engage professionals and create an inter-professional collaborative practice directed by a local leader and an external facilitator, to optimize the integration of a T2D primary prevention program:
- A strategy focused on the sequential activation: started in nursing, which finally manages to involve the whole center
- A global strategy with the participation of all professionals from the beginning
All centres and PHC professionals will receive training on current guidelines and scientific evidence in primary prevention of T2D and effective interventions to promote healthy lifestyles. Headed by a local leader and an external facilitator, centres will conduct a collaborative structured process to model and adapt the intervention and its implementation to the specific context of professionals and centres, and the determinants of T2D prevention practice. One of the groups will perform this strategy globally, promoting the cooperation of all health professionals from the beginning. The other will perform it sequentially, centred first in nursing, who will lately seek the pragmatic cooperation of physicians and other professionals.
All patients without diabetes aged ≥30 years old who attend at least once in collaborating centres at high risk of developing T2DM (FINDRISC> = 14 points and / or intermediate hyperglycaemia) will be eligible for program inclusion. The main outcome measures focus on observed changes in T2DM prevention clinical practice at centre level after 12 and 24 months, as a result of the implementation of one or another engagement strategy. Secondary outcomes will compare their clinical effectiveness in changing exposed eligible patients' main cardio-metabolic risk factors (Weight, BMI, Cholesterol, Glucose, Triglycerides) and lifestyles behaviours (physical activity and diet) after 12 months.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Bilbao, Spanje
- Primary Care Research Unit of Bizkaia, OSAKIDETZA
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- All patients without diabetes aged ≥30 years old who attend at least once in collaborating centres at high risk of developing T2DM (Body Mass Index >=25 or intermediate hyperglycaemia) will be eligible for program inclusion.
Exclusion Criteria:
-
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Onderzoek naar gezondheidsdiensten
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Dubbele
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Sequential engagement
Inter-professional collaborative practice directed by a local leader and an external facilitator to optimize the integration of a T2D primary prevention recommended clinical intervention.
In this group, a sequential engagement of professional categories, initiated in nursing, which finally involves the whole professional groups of the center (eg.
physicians, etc), will be followed
|
3 actions for the prevention of DM2 in the clinical setting are recommended:
|
|
Actieve vergelijker: Global engagement
Inter-professional collaborative practice directed by a local leader and an external facilitator to optimize the integration of a T2D primary prevention recommended clinical intervention.
In this group, a global strategy of engagement with the participation of all professionals from the beginning, will be followed
|
3 actions for the prevention of DM2 in the clinical setting are recommended:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Implementation of the recommended clinical intervention by health care porfessionals
Tijdsspanne: 12 months
|
The proportion of non-diabetic patients at high risk of developing DM2 exposed to the recommended intervention actions : assessing habits, personalized advice, prescription of lifestyle change plans and follow-up
|
12 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Lifestyle change at patient level
Tijdsspanne: 12 months
|
Proportion of exposed patients who change their habits (physical activity and diet) and lose 5% of their body weight
|
12 months
|
Medewerkers en onderzoekers
Sponsor
Publicaties en nuttige links
Algemene publicaties
- Sanchez A, Pablo S, Garcia-Alvarez A, Dominguez S, Grandes G; PREDIAPS Group. Effectiveness of two procedures for deploying a facilitated collaborative modeling implementation strategy-the PVS-PREDIAPS strategy-to optimize type 2 diabetes prevention in primary care: the PREDIAPS cluster randomized hybrid type II implementation trial. Implement Sci. 2021 May 27;16(1):58. doi: 10.1186/s13012-021-01127-x.
- Sanchez A, Rogers HL, Pablo S, Garcia E, Rodriguez I, Flores MA, Galarza O, Gaztanaga AB, Martinez PA, Alberdi E, Resines E, Llarena AI, Grandes G; PREDIAPS Group. Fidelity evaluation of the compared procedures for conducting the PVS-PREDIAPS implementation strategy to optimize diabetes prevention in primary care. BMC Fam Pract. 2021 Feb 11;22(1):34. doi: 10.1186/s12875-021-01378-z.
- Sanchez A, Grandes G, Pablo S, Espinosa M, Torres A, Garcia-Alvarez A; PREDIAPS Group. Engaging primary care professionals in collaborative processes for optimising type 2 diabetes prevention practice: the PREDIAPS cluster randomised type II hybrid implementation trial. Implement Sci. 2018 Jul 11;13(1):94. doi: 10.1186/s13012-018-0783-0.
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- PI15/00350
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Gerandomiseerde gecontroleerde studie
-
Fujian Medical University Union HospitalWervingeen gerandomiseerde gecontroleerde trialChina
-
Ain Shams UniversityOnbekendGerandomiseerde controle trialEgypte
-
Universiti Putra MalaysiaUniversity of LahoreVoltooidAdolescent | Gezondheidsbevordering | Tandplak | Cluster gerandomiseerde trial | Mondhygiëne, mondgezondheid | PakistanPakistan
-
Global and Sexual Health (GloSH)VoltooidMentale gezondheid | Huiselijk geweld | Partnergeweld | Interventie | Secundaire preventie | Probleembeheer plus | Cluster gerandomiseerde trialNepal
-
Second Affiliated Hospital of Wenzhou Medical UniversityBeëindigdOnderdompeling Virtual Reality Training, beroerte, bovenste extremiteit, gerandomiseerde gecontroleerde trialChina
-
Balgrist University HospitalIndustry (Schülke & Mayr AG, Switzerland and Germany)VoltooidElectieve Chirurgie | Hoog risico | Preventie van postoperatieve wondinfecties | Gerandomiseerde gecontroleerde trialZwitserland
-
Jinling Hospital, ChinaNog niet aan het wervenIntracraniaal aneurysma | CT-angiografie | Cluster gerandomiseerde trial | AI (kunstmatige intelligentie)
-
Ospedale Sandro Pertini, RomaVoltooidAloë Vera Gel, Proctosigmoiditis, Remissie, Trial, Colitis Ulcerosa (UC)
-
Kun SunBill and Melinda Gates FoundationVoltooidAangeboren hartziekte (CHD) | Cluster gerandomiseerde trial | Auscultatie voor klinische evaluatie | Controle instrument | Kunstmatige intelligentie (AI)China
Klinische onderzoeken op Healthy lifestyle prescription
-
Hacettepe UniversityMustafa Kemal University; University of DerbyVoltooidGeluk | Posttraumatische stressstoornissen | WelzijnTurkije (Türkiye)
-
The University of Texas Health Science Center,...American Heart AssociationWervingVoedingstekorten tijdens de zwangerschapVerenigde Staten
-
Baylor College of MedicineVoltooidObesitasVerenigde Staten
-
Marmara UniversityNog niet aan het wervenFysieke activiteit | Gezondheid van kinderen | Obesitas en overgewichtKalkoen
-
University of Alabama, TuscaloosaNational Institute of Mental Health (NIMH)WervingDepressieve symptomen | Angst SymptomenVerenigde Staten
-
The University of Texas at ArlingtonUniversity of South Florida; Center for Transportation, Equity, Decisions and...VoltooidGebrek aan middelen | Gebrek aan mobiliteitVerenigde Staten
-
Pavol Jozef Safarik UniversityUniversity of GroningenIngetrokken
-
University of Wisconsin, MadisonChan Zuckerberg InitiativeVoltooid
-
Iowa State UniversityAanmelden op uitnodiging
-
University of Wisconsin, MadisonVoltooidPsychische nood | Eenzaamheid | Depressie, angstVerenigde Staten